| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 2399 |
| Sex | Female |
| Age Range | 18-29, 30-44 |
| Body Types | Overweight |
800mg of DHA supplementation (via three 500mg omega-3 capsules) in pregnant women has failed to reduce the risk of pre-eclampsia, but appeared to be associated with reduced infant death (from a rate of 1.2% in control to 0.2% in DHA).
